Comparison Of Clinical Function Based on The Boston Carpal Tunnel Syndrome Questionnaire In Carpal Tunnel Syndrome With Carpal Tunnel Injections

Perbandingan Fungsi Klinis Berdasarkan Boston Carpal Tunnel Syndrome Questionnaire pada Sindroma Carpal Tunnel dengan Injeksi Carpal Tunnel

Abstract

Introduction: Carpal tunnel syndrome (CTS) is the most common compressive neuropathy. The definitive therapy for carpal tunnel syndrome is surgical decompression. Steroid injections have advantages for treating CTS because of their rapid effect. Steroid injections can reduce the inflammatory effects that occur in CTS by inhibiting the production of proinflammatory cytokines. Symptoms of carpal tunnel syndrome can be measured using the Boston Carpal Tunnel Syndrome Questionnaire (BCTQ). This study aims to analyze differences in clinical function based on the BCTQ in carpal tunnel syndrome patients with carpal tunnel injection.

Methods: This research is analytical experimental research with a quasi-experimental pretest posttest one group only design, conducted at H. Adam Malik General Hospital in May - December 2023. Patient data was obtained from medical records of patients undergoing injection procedures. Patients who met the inclusion criteria were interviewed and calculated by the BCTQ. Data is collected, then sorted systematically and analyzed through a computer-based statistical analysis program. Limitation of significance if p ≤ 0.05.

Results: Based on symptom severity scale and functional status scale, 20 mg and 40 mg Triamcinolone acetonide injection are significant between before and after injection at one, three, and six months monitoring with a p-value of 0.001 (p<0.05).

Conclusions: Carpal tunnel injection with Triamcinolone acetonide 20 mg and 40 mg can provide good clinical outcomes in cases of carpal tunnel syndrome and can reduce the severity of symptoms and provide a good scale of hand functional status.

Level of Evidence: This study is level 2 retrospective cohort study.